Author

Akira Chikamoto

Observed names: AKIRA CHIKAMOTO, Akira CHIKAMOTO, Chikamoto Akira, Chikamoto, Akira

Institutions: National Institute of Technology, Tsuyama College, Kumamoto University Hospital

Observed institutions: University of California, Los Angeles, National Institute of Technology, Tsuyama College, Kumamoto University Hospital, Kumamoto Chuo Hospital, Kumamoto Regional Medical Center, Institute of Resource Development and Analysis, Kumamoto University, Kumamoto University, Meijo University

OpenAlex ID: A5112548097

Controlling Nutritional Status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection

2017 · Daisuke Kuroda, Hiroshi Sawayama, et al. · Gastric Cancer · 343

PDF

Tumour-infiltrating inflammatory and immune cells in patients with extrahepatic cholangiocarcinoma

2017 · Yuki Kitano, Hirohisa Okabe, et al. · British Journal of Cancer · 144

PDF

An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression

2015 · Hiromitsu Hayashi, Takaaki Higashi, et al. · Cancer Research · 135

The microbiome and hepatobiliary-pancreatic cancers

2017 · Kosuke Mima, Shigeki Nakagawa, et al. · Cancer Letters · 134

Clinical and Prognostic Features of Patients With Esophageal Cancer and Multiple Primary Cancers

2017 · Yoshifumi Baba, Naoya Yoshida, et al. · Annals of Surgery · 114

Liver functional volumetry for portal vein embolization using a newly developed 99mTc-galactosyl human serum albumin scintigraphy SPECT–computed tomography fusion system

2011 · Toru Beppu, Hiromitsu Hayashi, et al. · Journal of Gastroenterology · 100

Chemotherapy and Targeted Therapy for Patients with Initially Unresectable Colorectal Liver Metastases, Focusing on Conversion Hepatectomy and Long-Term Survival

2014 · Toru Beppu, Yuji Miyamoto, et al. · Annals of Surgical Oncology · 95

Comparison between hepatic resection and radiofrequency ablation as first‐line treatment for solitary small‐sized hepatocellular carcinoma of 3 cm or less

2012 · Kastunori Imai, Toru Beppu, et al. · Hepatology Research · 89

Functional assessment versus conventional volumetric assessment in the prediction of operative outcomes after major hepatectomy

2014 · Hiromitsu Hayashi, Toru Beppu, et al. · Surgery · 79

The role of intestinal bacteria in the development and progression of gastrointestinal tract neoplasms

2017 · Kosuke Mima, Shuji Ogino, et al. · Surgical Oncology · 78

Preoperative controlling nutritional status (CONUT) is useful to estimate the prognosis after esophagectomy for esophageal cancer

2017 · Naoya Yoshida, Kazuto Harada, et al. · Langenbeck s Archives of Surgery · 73

The Prognostic Impact of Controlling Nutritional Status (CONUT) in Intrahepatic Cholangiocarcinoma Following Curative Hepatectomy: A Retrospective Single Institution Study

2017 · Tatsunori Miyata, Yo‐ichi Yamashita, et al. · World Journal of Surgery · 72

PD ‐L1 expression enhancement by infiltrating macrophage‐derived tumor necrosis factor‐α leads to poor pancreatic cancer prognosis

2018 · Masayo Tsukamoto, Katsunori Imai, et al. · Cancer Science · 71

PDF

Pancreatoduodenectomy using a no-touch isolation technique

2008 · Masahiko Hirota, Keiichiro Kanemitsu, et al. · The American Journal of Surgery · 70

Cystine/glutamic acid transporter is a novel marker for predicting poor survival in patients with hepatocellular carcinoma

2012 · HIROKI KINOSHITA, HIROHISA OKABE, et al. · Oncology Reports · 67

PDF

Enhancer of Zeste Homolog 2 (EZH2) Promotes Progression of Cholangiocarcinoma Cells by Regulating Cell Cycle and Apoptosis

2013 · Shigeki Nakagawa, Hirohisa Okabe, et al. · Annals of Surgical Oncology · 66

Microvascular invasion of single small hepatocellular carcinoma ≤3 cm: Predictors and optimal treatments

2018 · Yo‐ichi Yamashita, Katsunori Imai, et al. · Annals of Gastroenterological Surgery · 65

PDF

LINE-1 Methylation Level and Patient Prognosis in a Database of 208 Hepatocellular Carcinomas

2014 · Kazuto Harada, Yoshifumi Baba, et al. · Annals of Surgical Oncology · 65

Epithelial-mesenchymal transition expression profiles as a prognostic factor for disease-free survival in hepatocellular carcinoma: Clinical significance of transforming growth factor-β signaling

2012 · KOSUKE MIMA, HIROMITSU HAYASHI, et al. · Oncology Letters · 65

PDF

Lysyl oxidase induces epithelial‐mesenchymal transition and predicts intrahepatic metastasis of hepatocellular carcinoma

2019 · Naoki Umezaki, Shigeki Nakagawa, et al. · Cancer Science · 57

PDF

Statin attenuates cell proliferative ability via TAZ (WWTR1) in hepatocellular carcinoma

2016 · Takaaki Higashi, Hiromitsu Hayashi, et al. · Medical Oncology · 57

Sarcopenia, but not visceral fat amount, is a risk factor of postoperative complications after major hepatectomy

2015 · Takaaki Higashi, Hiromitsu Hayashi, et al. · International Journal of Clinical Oncology · 55

Sarcopenia Affects Systemic and Local Immune System and Impacts Postoperative Outcome in Patients with Extrahepatic Cholangiocarcinoma

2019 · Yuki Kitano, Yo‐ichi Yamashita, et al. · World Journal of Surgery · 52

Downregulation of 15‐hydroxyprostaglandin dehydrogenase by interleukin‐1β from activated macrophages leads to poor prognosis in pancreatic cancer

2017 · Kota Arima, Yoshihiro Komohara, et al. · Cancer Science · 52

PDF

C5a receptor (CD88) promotes motility and invasiveness of gastric cancer by activating RhoA

2016 · Takayoshi Kaida, Hidetoshi Nitta, et al. · Oncotarget · 52

PDF

Works count: 331

Citation count: 5,290

H-index: 38

I10-index: 144